Novel Biologics Will Reshape Cancer Therapy by 2018, Affordability Key Challenge

March 2012, Vol 3, No 2

Researchers at Espicom Business Intelligence, a medical and pharmaceutical market analysis company, predict that the development of novel biologic approaches to drug therapy will bring "a sea change" to the approach to cancer therapy, by focusing on controlling solid tumors and the introduction of new drugs that target new pathways. These drugs could be on the market in the next 5 years, the researchers suggest, and that is expected to change the face of cancer therapy, based on current directions in biologic drug research. "Novel approaches in the development of new drugs along with broader mechanism of action for existing therapeutic approaches will bring real clinical benefits to patients and will have fewer side effects. The challenge for industry and for society alike will be the affordability of these products," said Sue Viney, Senior Oncology Analyst at Espicom. Chichester, UK; Targeted Cancer Drugs; February 9, 2012.

Related Articles